Navigation Links
Nile Therapeutics Receives NASDAQ Notice; Will Request Hearing
Date:12/3/2010

SAN MATEO, Calif., Dec. 3, 2010 /PRNewswire/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced that, as anticipated, on November 30, 2010, the Company received a letter from the Listing Qualifications Staff (the "Staff") of The NASDAQ Stock Market (the "Staff Determination") notifying the Company that, based on its failure to regain compliance with the $1.00 minimum bid price requirement, as set forth in NASDAQ Listing Rule 5550(a)(2), the Company's common stock would be subject to delisting from The NASDAQ Capital Market unless the Company requests a hearing before the NASDAQ Listing Qualifications Panel (the "Panel").

The Company intends to request a hearing before the Panel, which will stay any action with respect to the Staff Determination until the Panel renders a decision subsequent to the hearing.  There can be no assurance that following the hearing the Panel will grant the Company's request for continued listing on The NASDAQ Capital Market.

The Staff Determination follows a notification from the Staff dated June 1, 2010, which was disclosed by the Company on June 4, 2010, indicating that the minimum bid price of the Company's common stock had been below $1.00 per share for 30 consecutive business days and that the Company had 180 calendar days, or until November 29, 2010, to regain compliance with the minimum bid price requirement.

About Nile Therapeutics

Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease and other areas of unmet medical needs. Nile is initially focusing its efforts on developing its lead compound, CD-NP, a novel rationally designed chimeric peptide in clinical studies for the treatment of heart failure, and CU-NP, a novel rat
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Halozyme Therapeutics Realigns Management
2. Cell Therapeutics Files Appeal on FDA Decision on New Drug Application (NDA) for Pixantrone to Treat Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma
3. The European Medicines Agency Validates and Accepts Cell Therapeutics Marketing Authorization Application for Pixuvri™
4. Nile Therapeutics Reports 2010 Third Quarter Financial Results
5. Ardea Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
6. ImmunGenes Pipeline of Next Generation Cancer Therapeutics Featured in BioWorld Today
7. Argos Therapeutics to Present Potential of its Arcelis™ Immunotherapy as an Innovative, Effective Treatment for HIV at the APHA 138th Annual Meeting & Exposition
8. Amicus Therapeutics Announces Third Quarter 2010 Financial Results
9. Mederi Therapeutics Announces Receipt of CE Mark for its Second Generation Secca® and Stretta® Systems
10. Pervasis Therapeutics Awarded Four Grants Under the Qualifying Therapeutic Discovery Project
11. Nektar Therapeutics Reports Third Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Revenue and earnings above the previous ... development In the past 2013/14 fiscal year (ended ... to EUR 4.287 billion (last year: EUR 4.190 billion) despite ... EUR 360 million. "Overall, 2013/14 was a successful fiscal year ... President and CEO of Carl Zeiss AG. "Thanks to our ...
(Date:12/17/2014)... YORK , Dec. 17, 2014 ... imaging (MRI), the MRI market is seeing new ... and breast MRI scans account for the majority ... a higher resolution of images, which are creating opportunities ... imaging (MRI) market is growing at a rate ...
(Date:12/17/2014)... 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: ... Office (USPTO) has issued a key patent covering ... vaccine targeting six tumor antigens that are commonly ... No. 8,871,211, which issued October 28, 2014, include ... dendritic cell composition comprising peptide epitopes of the ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2
... Mardil Inc., a cardiac device company with novel ... advanced its device to first-in-human testing, a milestone ... was successfully implanted with the Mardil device last ... improvement in heart function after the procedure, according ...
... expanded reimbursement coverageMINNEAPOLIS, Jan. 26 Uroplasty, Inc. (Amex: ... patient enrollment in the randomized, controlled multicenter clinical study ... of overactive bladder (OAB) symptoms of urinary urgency, urge ... of 214 patients have enrolled two months ahead of ...
Cached Medicine Technology:Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation 2Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule 2Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule 3Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule 4
(Date:12/17/2014)... Expectant parents should leave prenatal picture-taking to medical professionals, ... of ultrasound imaging and heartbeat monitors to get "keepsake" ... warns. "Although there is a lack of ... heartbeat monitors, prudent use of these devices by trained ... biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... Doheny HealthDay Reporter , TUESDAY, ... rampant in America, and work commitment is a big reason ... sleep killer," said Dr. Mathias Basner, an assistant professor of ... Perelman School of Medicine. A time-use survey of nearly ... is the main activity exchanged for sleep. Short sleepers -- ...
(Date:12/15/2014)... Beach, FL (PRWEB) December 15, 2014 South ... , knows that holidays can be a daze of hassle, ... slips and falls while decking halls, to burns when making ... of holiday hazards that can happen at any time. To ... pain, MD Now has made a list of helpful and ...
(Date:12/15/2014)... 14, 2014 (HealthDay News) -- Expert pilots process visual ... why they make better decisions during landings, a new ... difficult techniques for pilots to master, and 36 percent ... crashes occur during final approach and landing. Researchers ... 12 moderately experienced pilots while they were at the ...
(Date:12/15/2014)... December 15, 2014 At the leading, ... AutismOne and Focus Autism will ... with research on the effects of toxins to children’s ... intervention information. , Luminaries such as Dr. Lucija ... abroad with esteemed, credentialed colleagues of the United States ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... 1, 2010) Robotic surgical technology with its ... touch, even as they operate from a remote ... intersensory integration, and reports that surgical outcomes for ... compare favorably with traditional invasive surgery. Led by ...
... better than a "salt tax," study finds , MONDAY, ... to reduce U.S. sodium consumption by as little as ... of dollars, according to new research. , Cutting salt ... attacks and stroke. , "Per person on average it ...
... Mediterranean regimens all help the heart, study finds , ... three heart-healthy diets -- low-fat, low-carbohydrate, Mediterranean -- can ... to heart attack and stroke, an Israeli study indicates. ... though you experience only a moderate weight loss, if ...
... apt to enhance verbal skills, experts say, , MONDAY, ... their infants in front of supposedly brain-enhancing DVDs in ... be accomplishing nothing, new research shows. , What,s more, ... DVDs at an earlier age actually had lower levels ...
... , ... ... ... ...
... ... ... , , ... DALLAS , March ...
Cached Medicine News:Health News:Prostate cancer surgeons 'feel' with their eyes 2Health News:Prostate cancer surgeons 'feel' with their eyes 3Health News:Cutting Salt Could Prevent Almost 500,000 Heart Attacks 2Health News:Cutting Salt Could Prevent Almost 500,000 Heart Attacks 3Health News:Popular Diet Plans Can Unclog Arteries 2Health News:Watching Special Videos May Not Make Kids Brainier 2Health News:Watching Special Videos May Not Make Kids Brainier 3Health News:GNC Says 'Thank You' to Customers and Employees for Their $1.4 Million in Donations to the Sixth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Health News:GNC Says 'Thank You' to Customers and Employees for Their $1.4 Million in Donations to the Sixth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3Health News:GNC Says 'Thank You' to Customers and Employees for Their $1.4 Million in Donations to the Sixth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 4Health News:GNC Says 'Thank You' to Customers and Employees for Their $1.4 Million in Donations to the Sixth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 5Health News:National Sleep Awareness Week(R) (March 7-13): How Are You Sleeping? 2Health News:National Sleep Awareness Week(R) (March 7-13): How Are You Sleeping? 3Health News:National Sleep Awareness Week(R) (March 7-13): How Are You Sleeping? 4Health News:National Sleep Awareness Week(R) (March 7-13): How Are You Sleeping? 5
Athouritative, on the spot answers for acute care and consultations....
... The SphygmoCor Mx Central Blood Pressure ... the SphygmoCor Px system by providing ... pressure waveform., ,Key cardiovascular parameters are ... These parameters include:, Central Systolic, ...
Bio-Rad's Genetic Systems HIV-1/HIV-2 PLUS O EIA is a unique assay that detects the broadest range of HIV....
The humidity chamber maintains a moist environment during immunostaining procedures as well as other laboratory procedures requiring controlled incubation steps....
Medicine Products: